ANAB vs CPT · rev $234.6M vs P/E 104, rev $5.3M
AnaptysBio Inc (ANAB) versus Camden Property Trust (CPT) — a side-by-side from cached financials, not a winner call.
AnaptysBio Inc (ANAB) is a biotechnology company listed on NASDAQ.
Camden Property Trust (CPT) is a reit - residential company listed on US.
Latest reported ANAB revenue for 2025-12-31 was $234.6M. Net income was -$13.2M. Revenue was up 157.0% from 2024-12-31 to 2025-12-31. ANAB currently screens at market cap $1.62B.
Latest reported CPT revenue for 2026-06-30 was $5.3M. Net income was $61.2M. CPT currently screens at market cap $12.11B and trailing P/E 104.0.
ANAB currently screens at market cap $1.62B. CPT currently screens at market cap $12.11B and trailing P/E 104.0.
Not investment advice. Open the ANAB and CPT stock pages for the full models.
Not investment advice.